1. |
- Jin, Ying-Hui, et al.
(författare)
-
Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19 : An evidence-based clinical practice guideline (updated version)
- 2020
-
Ingår i: Military Medical Research. - : Springer Science and Business Media LLC. - 2054-9369. ; 7:1
-
Tidskriftsartikel (refereegranskat)abstract
- The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of a rapidly spreading illness, coronavirus disease 2019 (COVID-19), affecting more than seventeen million people around the world. Diagnosis and treatment guidelines for clinicians caring for patients are needed. In the early stage, we have issued "A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)"; now there are many direct evidences emerged and may change some of previous recommendations and it is ripe for develop an evidence-based guideline. We formed a working group of clinical experts and methodologists. The steering group members proposed 29 questions that are relevant to the management of COVID-19 covering the following areas: chemoprophylaxis, diagnosis, treatments, and discharge management. We searched the literature for direct evidence on the management of COVID-19, and assessed its certainty generated recommendations using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach. Recommendations were either strong or weak, or in the form of ungraded consensus-based statement. Finally, we issued 34 statements. Among them, 6 were strong recommendations for, 14 were weak recommendations for, 3 were weak recommendations against and 11 were ungraded consensus-based statement. They covered topics of chemoprophylaxis (including agents and Traditional Chinese Medicine (TCM) agents), diagnosis (including clinical manifestations, reverse transcription-polymerase chain reaction (RT-PCR), respiratory tract specimens, IgM and IgG antibody tests, chest computed tomography, chest x-ray, and CT features of asymptomatic infections), treatments (including lopinavir-ritonavir, umifenovir, favipiravir, interferon, remdesivir, combination of antiviral drugs, hydroxychloroquine/chloroquine, interleukin-6 inhibitors, interleukin-1 inhibitors, glucocorticoid, qingfei paidu decoction, lianhua qingwen granules/capsules, convalescent plasma, lung transplantation, invasive or noninvasive ventilation, and extracorporeal membrane oxygenation (ECMO)), and discharge management (including discharge criteria and management plan in patients whose RT-PCR retesting shows SARS-CoV-2 positive after discharge). We also created two figures of these recommendations for the implementation purpose. We hope these recommendations can help support healthcare workers caring for COVID-19 patients.
|
|
2. |
- Reimers, Jeffrey R., et al.
(författare)
-
Challenges facing an understanding of the nature of low-energy excited states in photosynthesis
- 2016
-
Ingår i: Biochimica et Biophysica Acta - Bioenergetics. - : Elsevier BV. - 0005-2728 .- 1879-2650. ; 1857:9, s. 1627-1640
-
Forskningsöversikt (refereegranskat)abstract
- While the majority of the photochemical states and pathways related to the biological capture of solar energy are now well understood and provide paradigms for artificial device design, additional low-energy states have been discovered in many systems with obscure origins and significance. However, as low-energy states are naively expected to be critical to function, these observations pose important challenges. A review of known properties of low energy states covering eight photochemical systems, and options for their interpretation, are presented. A concerted experimental and theoretical research strategy is suggested and outlined, this being aimed at providing a fully comprehensive understanding.
|
|
3. |
- He, Jianqiao, et al.
(författare)
-
Ferrocene-integrated conjugated microporous polymer nanosheets : Active and regenerative catalysts for photomediated controlled radical polymerization
- 2020
-
Ingår i: Applied materials today. - : Elsevier BV. - 2352-9407. ; 18
-
Tidskriftsartikel (refereegranskat)abstract
- The challenge of light-driven controlled radical polymerization through non-noble metal catalyst remains the most significant issue. Ferrocene-bearing microporous aromatic polymer nanosheets (termed FeMAP-11) that feature high chemical stability were reported here to synergistically combine the advantageous properties of the redox-active ferrocene units and the conjugated microporous polymers (CMPs), and to be able to serve as photocatalyst for activators regenerated by electron transfer atom transfer radical polymerization (AGET-ATRP). It succeeded in initiating polymerizations of 3 common vinyl monomers, i.e. methyl methacrylate (MMA), methacrylate (MA) and styrene (St), and produced polymers with controlled molecular weight and relatively low molecular weight dispersity ((1) over tilde .3). Benefiting from steric hindrance through ketone-amine chemistry, the microporous catalyst with tolerance to acidic and basic media was found stable under the AGET-ATRP conditions. It showed negligible metal leaching and good recyclability for at least 10 cycles without sacrifice of its catalytic performance. Our tests proved that FeMAP-11 exceeded the state-of-the-art ATRP photocatalysts such as UiO-66-NH2, titanium MOF-901 and the commercial P-25 Titania, demonstrating promising potential in catalysis in view of green chemistry.
|
|